ClinicalTrialsFinder
RecruitingPhase 2NCT05995769

Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder

Mechanisms Supporting Psilocybin-assisted Psychotherapy for Alcohol Use Disorder: A Randomized, Controlled Clinical Trial

Sponsor

University of Calgary

Enrollment

128 participants

Start Date

Mar 20, 2024

Study Type

INTERVENTIONAL

Conditions

AlcoholismAlcohol Use Disorder

Summary

The aim of this study is to determine if a single dose of psilocybin administered with motivational enhancement therapy (MET) can reduce heavy drinking in patients with an alcohol use disorder (AUD).

Eligibility

Min Age: 22 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Psilocybin for people with alcohol use disorder and alcoholism. The study is currently recruiting participants at 1 location. People eligible for this study include aged 22 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPsilocybin

Single dosing session followed by 5 MET weekly sessions starting 24hrs after dosing

Locations(1)

University of Calgary

Calgary, Alberta, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05995769

Related Trials

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

NCT066760591 location

Environment and Alcohol: A Pilot Study

NCT068606071 location

Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool

NCT066187551 location

PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder

NCT067955811 location

Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)

NCT056773211 location